Dr. Dhwanee Thakkar

Senior Consultant

23 Years of Experience

Medical Oncologist

MBBS, MD, FNB, Fellowship

Reg. No.:40415, Gujarat Medical Council

Medanta - The Medicity Hospital, Gurgaon

English

Consultation Fee ₹ 1000

Book an Appointment

About Dr. Dhwanee Thakkar

Dr. Dhwanee Thakkar is a well-known Medical Oncologist with over 23 years of experience.
She is proficient in managing various Coagulation Disorders, including Hemophilia, von Willebrand Disease, and Rare Bleeding Disorders.
After completing her MBBS from Surat Municipal Institute of Medical Education and Research (SMIMER), 2007, she also achieved MD (Pediatrics) from Surat Municipal Institute of Medical Education and Research, (SMIMER), 2012, and FNB (Pediatric Hematology-Oncology) from Sri Ganga Ram Hospital, 2015.
Dr. Thakkar also achieved a Fellowship in Paediatric Haematology Oncology and Bone Marrow Transplant from Sri Ganga Ram Hospital in 2015 and a Fellowship in Haemostasis and Thrombosis) from the Royal Infirmary of Edinburgh in 2018.
She actively participates in conferences, seminars, and workshops.
She has authored several books and papers presented at national and international conferences.
Dr. Thakkar is a member of the International Society on Thrombosis and Haemostasis and the Indian Paediatric Haematology Oncology Group.

Book Your Appointment With Dr. Dhwanee Thakkar

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS, Surat Municipal Institute of Medical Education and Research (SMIMER), 2007
MD (Pediatrics), Surat Municipal Institute of Medical Education and Research, (SMIMER), 2012
FNB (Pediatric Hematology-Oncology), Sri Ganga Ram Hospital, 2015
Fellowship (Paediatric Haematology Oncology and Bone Marrow Transplant), Sri Ganga Ram Hospital, 2015
Fellowship (Haemostasis and Thrombosis), Royal Infirmary of Edinburgh, 2018

Past Experience

Fortis Memorial Research Institute, Gurgaon
Ram Manohar Lohia Hospital, New Delhi

Awards

Access to Insight Scholarship for advanced training in Haemostasis and Thrombophilias at Edinburgh, Scotland, 2017.
Received Travelling Scholarship for the 17th Biennial Meeting of the European Society for Immunodeficiencies (ESID), 2016.
Received a scholarship for attending Masterclass in Pediatric Surgical Oncology, organized at AIIMS, New Delhi, under the aegis of EUPSA, 2015.
Gold Medal for MD Paediatrics, 2012.

Associations/Membership

International Society on Thrombosis and Haemostasis
Indian Paediatric Haematology Oncology Group

Paper Published

Treating childhood acute lymphoblastic leukemia relapse post haploidentical stem cell transplant with car-T cell therapy
Inotuzumab as a bridge to hematopoietic stem cell transplant in children with relapse/refractory acute lymphoblastic leukemia
Successful TCR alpha/beta depleted haploidentical hematopoietic stem cell transplantation for severe combined immunodeficiency.
Donor type aplasia in a pediatric patient with severe aplastic anemia post haploidentical transplantation: A case report.
Incidence, Risk Factors, Characteristics, and Outcome of Chronic Graft Versus Host Disease in Children Undergoing Haploidentical Peripheral Blood Stem Cell Transplant With Post-Transplant Cyclophosphamide.
Fatal Severe Cytokine Release Syndrome Post-haploidentical Stem Cell Transplant With Post-transplant Cyclophosphamide in an Infant With Severe Combined Immunodeficiency and Disseminated Bacille Calmette-Guérin Infection.
Critical Care Needs and Outcome of Pediatric T cell Lymphoblastic Leukemia or Lymphoma with Superior Venacaval Syndrome.
Posterior reversible encephalopathy syndrome (PRES) in pediatric hematology, oncology and post hematopoietic stem cell transplant: A single centre experience.
Cytokine release syndrome with immune reconstitution inflammatory syndrome post haploidentical hematopoietic stem cell transplantation in a child with severe combined immunodeficiency and disseminated BCG infection.
Treatment of pediatric acute lymphoblastic leukemia in India on BFM 95 protocol backbone with relevant modifications and minimal residual disease application - Doable and effective
Impact of graft cd3 lymphocyte cell dose on clinical outcomes in pediatric patients undergoing haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide.
Post COVID-19 multisystem inflammatory syndrome in children undergoing hematopoietic stem cell transplant
Fatal pneumonia, hyperinflammation, and digital gangrene caused by human coronavirus in a child post haploidentical stem cell transplant.
Thiotepa Based Conditioning for Haploidentical Stem Cell Transplantation with Post Transplant Cyclophosphamide for Pediatric Acute Leukemia Is Highly Effective.
Non-myeloablative matched sibling donor peripheral blood stem cell transplant is curative for Human Heme-Oxygenase-1 Deficiency.
Allogeneic Stem Cell Transplantation with Post Transplant Cyclophosphamide in Children with Thalassemia Major Reduced-toxicity alternate-donor stem cell transplantation with posttransplant cyclophosphamide for primary immunodeficiency disorders.
T-Cell Replete Haploidentical Stem Cell Transplantation with Post Transplant Cyclophosphamide in Hemoglobinopathies: A Single Centre Experience.